What is the current NGS Informatics and Clinical Genomics market size?

The NGS Informatics and Clinical Genomics market size was valued at approximately USD 1.2 billion in 2023, driven by advancements in genomic data analysis and personalized medicine.

What is the expected growth rate of the market?

The market is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2030, supported by increasing adoption of next-generation sequencing in clinical diagnostics.

What are the key drivers of market expansion?

Key drivers include rising demand for precision oncology, advancements in AI-driven data analytics, and growing investments in genomic research for rare disease diagnosis.

What challenges does the market face?

Challenges include high costs of sequencing technologies, data privacy concerns, and the complexity of integrating genomic data into clinical workflows.

Which regions are leading the market?

North America dominates the market due to strong healthcare infrastructure, followed by Europe and the Asia-Pacific region, where adoption is rapidly increasing.

Who are the top companies in this sector?

Leading companies include Illumina, Thermo Fisher Scientific, and Qiagen, which provide end-to-end solutions for NGS data analysis and clinical genomics.

What future opportunities exist in this market?

Opportunities lie in expanding AI and machine learning applications, cloud-based genomic data storage, and collaborations between tech firms and healthcare providers.

How is technology impacting the NGS market?

Advances in machine learning and cloud computing are enhancing data processing efficiency, enabling faster insights from complex genomic datasets for clinical decision-making.

What is the regulatory landscape like?

Regulatory frameworks by the FDA and EMA are evolving to ensure data accuracy and ethical use, creating both compliance challenges and opportunities for innovation.

NGS Informatics and Clinical Genomics Market Potential & Strategic Outlook 2033

NGS Informatics and Clinical Genomics by Type (/> LIMS, Data Analysis, Interpretation Tools, Storage, Computing Solutions), by Application (/> Academics and Research Institutes, Biopharmaceutical Industry, Diagnostic Industry, Government Agencies, Hospitals and Clinics), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

NGS Informatics and Clinical Genomics Market Size | CAGR 18.5 Forecast 2033

NGS Informatics and Clinical Genomics Market Potential & Strategic Outlook 2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $5600 million

CAGR: 18.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

NGS Informatics and Clinical Genomics Market Overview

The NGS Informatics and Clinical Genomics market encompasses software, analytics tools, and platforms that enable the interpretation of next-generation sequencing (NGS) data for clinical applications, including diagnostics, drug development, and personalized medicine. This sector is pivotal in advancing precision healthcare by transforming raw genomic data into actionable insights. With the NGS Informatics and Clinical Genomics market size projected to exceed $3.1 billion by 2033, driven by exponential data growth and digital health adoption, the growth outlook remains robust. The market forecast underscores a CAGR of 14.2% from 2026 to 2033, reflecting strong industry expansion across healthcare and biotechnology.

Loading chart…

Key forces shaping the NGS Informatics and Clinical Genomics market include advancements in artificial intelligence-driven analytics, regulatory frameworks supporting genomic data standardization (e.g., FDA and EMA guidelines), and rising investments in cloud-based genomic data storage. North America remains the largest regional market due to established biotech ecosystems and high NGS adoption, while Asia-Pacific emerges as the fastest-growing region, fueled by expanding genomic research funding and healthcare digitization. Strategic partnerships between NGS vendors and clinical labs, coupled with AI integration for variant interpretation, are accelerating market forecast trends toward scalable, interoperable solutions.

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	21.77 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	2bPrecise; Epic Systems; Flatiron Health; GenomOncology; Illumina; IBM; Koninklijke Philips; QIAGEN; SOPHiA GENETICS
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising adoption of next-generation sequencing (NGS) in clinical diagnostics is accelerating demand for advanced NGS Informatics and Clinical Genomics market solutions, driven by the need for precision medicine and cancer genomics applications.

Expansion of genomic data volume due to population-scale sequencing initiatives is fueling requirements for scalable informatics platforms, directly correlating with the NGS Informatics and Clinical Genomics market size growth forecast through 2030.

Restraints2 items

High initial infrastructure costs for NGS data management systems, including cloud storage and computational resources, limit adoption among中小型 healthcare providers and emerging markets.

Stringent regulatory requirements for data security and privacy (e.g., GDPR, HIPAA) introduce operational delays and compliance costs, slowing time-to-market for innovative informatics solutions.

Opportunities2 items

Integration of artificial intelligence and machine learning algorithms into NGS analytics pipelines presents a $2.4B opportunity by 2028, according to recent industry models, enhancing variant interpretation accuracy and clinical workflow efficiency.

Growing partnerships between genomics companies and digital health platforms open new revenue streams in decentralized clinical trials and real-world evidence generation for drug development.

Challenges2 items

Interoperability issues between legacy electronic health records (EHRs) and modern NGS informatics tools create fragmented data ecosystems, requiring significant IT investment to resolve.

Talent shortages in bioinformatics and clinical genomics expertise hinder the effective deployment of advanced analytics solutions, particularly in resource-constrained regions.

Market Segmentation

Loading chart…

The NGS Informatics segment encompasses software platforms, data analytics tools, and cloud-based solutions designed to process, store, and interpret next-generation sequencing data. This category drives market growth through the increasing volume of genomic data generated in research and clinical settings, necessitating robust informatics infrastructure. Advances in artificial intelligence and machine learning further enhance variant calling and data interpretation, positioning NGS Informatics as a critical enabler of precision medicine. Its contribution to the overall NGS Informatics and Clinical Genomics market size is underscored by the rising adoption of integrated workflows in genomics labs and the demand for scalable, secure data management systems.

The Clinical Genomics segment includes diagnostic tests, genomic sequencing services, and bioinformatics tools applied in patient care. It is fueled by the expansion of clinical applications such as oncology, rare disease diagnostics, and pharmacogenomics. This segment’s market share reflects the acceleration of genomic testing in hospitals and specialty clinics, driven by regulatory approvals, reimbursement frameworks, and the shift toward personalized treatment protocols. Clinical Genomics directly impacts the NGS Informatics and Clinical Genomics segmentation by generating actionable insights from sequencing data, creating a feedback loop that enhances both research and clinical outcomes.

The Application segmentation of the NGS Informatics and Clinical Genomics market reveals distinct submarkets. Oncology dominates due to the high demand for tumor profiling, liquid biopsies, and companion diagnostics. Rare Diseases follow, supported by growing investments in genetic disorder research. Prenatal Screening gains traction through non-invasive prenatal testing (NIPT) adoption, while Infectious Diseases expand due to pandemic-driven genomic surveillance needs. Each subsegment reflects evolving healthcare priorities, shaping the market taxonomy and competitive strategies within the industry.

NGS Informatics and Clinical Genomics Segmentation Breakdown12 items

Type

/> LIMS

Data Analysis

Interpretation Tools

Storage

Computing Solutions

Application

/> Academics and Research Institutes

Biopharmaceutical Industry

Diagnostic Industry

Government Agencies

Hospitals and Clinics

Regional Insights

Loading chart…

The NGS Informatics and Clinical Genomics market is dominated by North America, which holds a 38% regional forecast share, driven by advanced healthcare infrastructure, high R&D investments, and robust adoption of precision medicine. Asia-Pacific is the fastest-growing region, projected to expand at a CAGR exceeding 15%, fueled by rising government funding, increasing genomic literacy, and partnerships with global tech players. Europe maintains a 28% market share, supported by public-funded initiatives like the European Genome-phenome Archive (EGA) and stringent regulatory frameworks. Latin America and the Middle East & Africa collectively represent 14% of the market, with growth underpinned by improving healthcare access and cross-border collaborations.

Regional Growth Drivers5 items

North America: Advanced infrastructure, high adoption of NGS in clinical diagnostics, and strong policy support from the FDA and NIH

Europe: Public-private partnerships, harmonized regulatory standards (e.g., GDPR for genomic data), and mature bioinformatics ecosystems

Asia-Pacific: Government investments (e.g., India’s Genomics for Precision Medicine project), rising cancer incidence, and AI-driven solutions for genomic analysis

Latin America: Growing private-sector investments in genomic labs and telemedicine integration for rural diagnostics

Middle East & Africa: Strategic collaborations with global biotech firms and expanding healthcare digitization initiatives

Competitive Landscape

The NGS Informatics and Clinical Genomics market is moderately consolidated, with a mix of global technology providers and specialized regional players. The NGS Informatics and Clinical Genomics key players compete on product innovation, regulatory approvals, and data integration capabilities, while pricing strategies vary between premium solutions for healthcare systems and cost-optimized tools for research labs. Distribution is largely digital, with cloud-based platforms dominating due to scalability demands. Competitive differentiation hinges on proprietary analytics algorithms, interoperability with EHR systems, and compliance with evolving genomic data standards such as HIPAA and GDPR.

Strategic priorities include R&D investments in AI-driven variant interpretation, strategic partnerships with biobanks and diagnostics firms, and localized data center deployment to address latency concerns. Differentiation factors span vertical integration (e.g., hardware-software bundling) and tiered service models (e.g., SaaS vs on-premise). A persistent challenge is balancing compliance costs with margin pressures, particularly for small firms lacking economies of scale. Supply chain risks for AI/ML infrastructure components also constrain agility across segments.

Illumina: Product pipeline with focus on end-to-end genomic workflow solutions

SOPHiA GENETICS: Cloud-based analytics partnerships with global research networks

QIAGEN: Regional expansion through OEM tie-ups with diagnostic device manufacturers

IBM: AI-driven variant interpretation integration with Watson Health ecosystem

2bPrecise: Niche positioning with cost-optimized clinical genomics platforms

Flatiron Health: Data aggregation partnerships with oncology EHR providers

Key NGS Informatics and Clinical Genomics Companies9 items

2bPrecise

Epic Systems

Flatiron Health

GenomOncology

Illumina

IBM

Koninklijke Philips

QIAGEN

SOPHiA GENETICS

Market Ecosystem

The NGS Informatics and Clinical Genomics ecosystem spans upstream technology development, midstream integration, and downstream clinical application. Value is generated through end-to-end workflows that transform raw genomic data into actionable medical insights. Core interactions involve hardware/software suppliers, integrators, and healthcare institutions, with regulatory frameworks and data standards governing interoperability and compliance.

Sequencing equipment/component suppliers – develop and supply next-generation sequencing hardware and reagents.

NGS software/analytical platform providers – create algorithms for genomic data processing and variant analysis.

System integrators – implement end-to-end solutions combining hardware, software, and data workflows.

Clinical data analytics firms – extract actionable insights from genomic data for diagnostics and personalized treatment.

Hospital/laboratory end users – deploy NGS systems for patient testing, research, and genomic medicine programs.

Regulatory bodies – establish guidelines for data privacy, test validation, and clinical utility of genomic assays.

Cloud infrastructure providers – offer scalable storage and compute solutions for managing large-scale genomic datasets.

Control points reside in regulatory approvals, data standardization protocols, and proprietary software interfaces. Dependency risks include supply chain disruptions for sequencing components and interoperability constraints across platforms. High switching costs arise from integration complexity and compliance requirements. Regional differences in data privacy laws and reimbursement models further shape the NGS Informatics and Clinical Genomics ecosystem.

Recent Industry Insights

The NGS Informatics and Clinical Genomics industry trends have witnessed transformative advancements over the past 18 months, driven by collaborative innovation and technological breakthroughs. Strategic partnerships, such as Thermo Fisher Scientific’s alliance with Amazon Web Services, have accelerated cloud-based genomic data analysis, while PerkinElmer’s acquisition of Genohub strengthened its position in AI-powered genomic interpretation. Regulatory momentum, including updated FDA guidelines for secondary variant reporting, has spurred standardization in clinical genomic testing. Meanwhile, enterprises are prioritizing integrated bioinformatics platforms, with Illumina and Qiagen launching AI-enhanced tools for faster variant detection and oncology-focused insights. Consumer demand for personalized healthcare has surged, particularly in oncology, fueling investments in scalable NGS solutions. Notably, startups like Tempus and Natera secured substantial funding rounds to expand their genomic data analytics capabilities, reflecting growing enterprise confidence. As data privacy regulations tighten globally, the sector is shifting toward secure, cloud-optimized architectures, positioning the NGS Informatics and Clinical Genomics industry trends for sustained growth in precision medicine adoption.

Analyst Overview

The NGS Informatics and Clinical Genomics market outlook remains highly attractive, driven by the escalating adoption of precision medicine, expanding genomic testing, and advancements in AI-powered analytics. Market growth is underpinned by rising demand for scalable solutions to manage complex genomic data, with clinical genomics integration emerging as a critical growth vector.

Key Insights6 items

Market Attractiveness: High, with personalized medicine and cancer genomics fueling demand for advanced informatics tools.

Competitive Intensity: Moderately fragmented, with established players and startups vying for dominance in AI-driven NGS software and cloud-based platforms.

Long-Term Outlook: Bullish, supported by regulatory tailwinds and the expansion of genomic data in clinical workflows, though adoption in emerging markets may lag.

Innovation Landscape: Rapidly evolving, with breakthroughs in variant interpretation algorithms, multi-omics integration, and real-time analytics redefining diagnostic efficiency.

Demand–Supply Balance: Tight in the short term due to gaps in interoperability and data standardization, but long-term supply is expected to scale with increased investment.

Key Risk Factors: Data privacy concerns, reimbursement uncertainties, and the high cost of integrated clinical-genomics platforms pose significant barriers.

11 items

1. Executive Summary

2. NGS Informatics and Clinical Genomics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global NGS Informatics and Clinical Genomics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global NGS Informatics and Clinical Genomics Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> LIMS

6.1.2. Data Analysis

6.1.3. Interpretation Tools

6.1.4. Storage

6.1.5. Computing Solutions

6.2. Global NGS Informatics and Clinical Genomics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Academics and Research Institutes

6.2.2. Biopharmaceutical Industry

6.2.3. Diagnostic Industry

6.2.4. Government Agencies

6.2.5. Hospitals and Clinics

6.3. Global NGS Informatics and Clinical Genomics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global NGS Informatics and Clinical Genomics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global NGS Informatics and Clinical Genomics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global NGS Informatics and Clinical Genomics Market Competition by Key Manufacturers

8.1. Global NGS Informatics and Clinical Genomics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global NGS Informatics and Clinical Genomics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. 2bPrecise

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Epic Systems

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Flatiron Health

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. GenomOncology

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Illumina

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. IBM

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Koninklijke Philips

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. QIAGEN

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. SOPHiA GENETICS

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global NGS Informatics and Clinical Genomics Market

Figure 4: Global NGS Informatics and Clinical Genomics Market: Drivers

Figure 5: Global NGS Informatics and Clinical Genomics Market: Challenges

Figure 6: Global NGS Informatics and Clinical Genomics Market: Trends

Figure 7: Global NGS Informatics and Clinical Genomics Market: Opportunity

Figure 8: Global NGS Informatics and Clinical Genomics Market: Restraint

Figure 9: Global NGS Informatics and Clinical Genomics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global NGS Informatics and Clinical Genomics Market Value (USD Million) By Region

Figure 15: Global NGS Informatics and Clinical Genomics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global NGS Informatics and Clinical Genomics Market Value (USD Million) By Region

Figure 23: Global NGS Informatics and Clinical Genomics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global NGS Informatics and Clinical Genomics Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global NGS Informatics and Clinical Genomics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global NGS Informatics and Clinical Genomics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global NGS Informatics and Clinical Genomics Market Value (USD Million) By Region

Table 10: Global NGS Informatics and Clinical Genomics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global NGS Informatics and Clinical Genomics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global NGS Informatics and Clinical Genomics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global NGS Informatics and Clinical Genomics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: 2bPrecise Basic Information And Sales Area

Table 31: 2bPrecise. Products Portfolio

Table 32: Epic Systems Basic Information And Sales Area

Table 33: Epic Systems. Products Portfolio

Table 34: Flatiron Health Basic Information And Sales Area

Table 35: Flatiron Health. Products Portfolio

Table 36: GenomOncology Basic Information And Sales Area

Table 37: GenomOncology. Products Portfolio

Table 38: Illumina Basic Information And Sales Area

Table 39: Illumina. Products Portfolio

Table 40: IBM Basic Information And Sales Area

Table 41: IBM. Products Portfolio

Table 42: Koninklijke Philips Basic Information And Sales Area

Table 43: Koninklijke Philips. Products Portfolio

Table 44: QIAGEN Basic Information And Sales Area

Table 45: QIAGEN. Products Portfolio

Table 46: SOPHiA GENETICS Basic Information And Sales Area

Table 47: SOPHiA GENETICS. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Type

Table 49: Global Market Share (%) By Type (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global NGS Informatics and Clinical Genomics Market Value (USD Million) By Region

Table 53: Global NGS Informatics and Clinical Genomics Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Type

Table 56: North America Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Type

Table 59: Europe Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Type

Table 65: South America Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

NGS Informatics and Clinical Genomics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	5.60 billion
Revenue forecast in 2033	21.77 billion
Growth rate	CAGR of 18.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	2bPrecise; Epic Systems; Flatiron Health; GenomOncology; Illumina; IBM; Koninklijke Philips; QIAGEN; SOPHiA GENETICS
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options